Pinion Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,480
Closed -$299K 148
2021
Q2
$299K Sell
4,480
-474
-10% -$30.9K 0.24% 125
2021
Q1
$313K Buy
4,954
+335
+7% +$20.8K 0.29% 116
2020
Q4
$287K Sell
4,619
-823
-15% -$50.6K 0.3% 112
2020
Q3
$320K Hold
5,442
0.48% 83
2020
Q2
$320K Buy
+5,442
New +$326K 0.48% 83

Other funds holding BMY

Pinion Investment Advisors's BMY Position: Q3 2021 in Review

Pinion Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 4,480 shares — an estimated $299K sold.

Pinion Investment Advisors first reported a position in BMY in Q2 2020 and held it in 5 quarters. The position peaked at $320K in Q3 2020. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

  • Pinion Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
  • Pinion Investment Advisors sold 4,480 Bristol-Myers Squibb shares in Q3 2021, an estimated $299K.
  • Pinion Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2020 and held it in 5 quarters.
  • Pinion Investment Advisors's Bristol-Myers Squibb position peaked at $320K in Q3 2020.
  • 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Pinion Investment Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.